Neuropeptide Y is released together with norepinephrine from sympathetic nerve terminals during conditions of increased sympathetic activity. Neuropeptide Y is known to inhibit vagal activity, and accordingly, it might increase the risk for ventricular fibrillation during myocardial ischemia-reperfusion, with concomitant sympathetic stimulation. Counteracting the inhibiting effect of neuropeptide Y by the specific neuropeptide Y2 antagonist, BIIE0246, we expected occurrence of ventricular fibrillation in association with repeated periods of myocardial ischemia-reperfusion to decrease. The midleft anterior descending coronary artery was repeatedly occluded in 16 open-chest pigs. Eight pigs received BIIE0246, and the controls received the vehicle only. Ventricular fibrillation developed in 2 animals of the control group, but in 4 pigs receiving BIIE0246. Occurrence of ventricular fibrillation and ventricular tachycardia did not differ significantly between the 2 groups, and in association with repeated periods of regional myocardial ischemia, did not decline in pigs treated by the specific neuropeptide Y2-receptor antagonist BIIE0246.
Hjalmarson A.Effects of beta blockade on sudden cardiac death during acute myocardial infarction and the postinfarction period. Am J Cardiol. 1997;80: 35J-39J.
Lombardi F, Verrier RL, Lown B.Relationship between sympathetic neural activity, coronary dynamics, and vulnerability to ventricular fibrillation during myocardial ischemia and reperfusion. Am Heart J. 1983;105: 958-965.
4.
Malliani A, Schwartz PJ, Zanchetti A.A sympathetic reflex elicited by experimental coronary occlusion. Am J Physiol. 1969;217: 703-709.
5.
Lundberg JM.Pharmacology of cotransmission in the autonomic nervous system: integrative aspects on amines, neuropeptides, adenosine triphosphate, amino acids and nitric oxide. Pharmacol Rev.1996;48: 113-178.
6.
Franco-Cereceda A, Öwall A, Settergren G, Sollevi A, Lundberg JM.Release of neuropeptide Y and noradrena-line from the human heart after aortic occlusion during coronary artery surgery. Cardiovasc Res. 1990; 24: 242-246.
7.
Lundberg JM, Torssell L, Sollevi A, et al.Neuropeptide Y and sympathetic vascular control in man. Regul Pep. 1985;13: 41-52.
8.
Morris MJ, Russell AE, Kapoor V, et al.Increases in plasma neuropeptide Y concentrations during sympathetic activation in man. J Auton Nerv Syst.1986;17: 143-149.
9.
Zukowska-Grojec Z, Dayao EK, Karwatowska-Prokopczuk E, Hauser GJ, Doods HN.Stress-induced mesenteric vasoconstriction in rats is mediated by neuropeptide Y Y1 receptors. Am J Physiol. 1996;270: H796-H800.
10.
Potter EK.Neuropeptide Y as an autonomic neurotransmitter. Pharmac Ther. 1988;37: 251-273.
11.
Potter EK.Prolonged non-adrenergic inhibition of cardiac vagal action following sympathetic stimulation: neuromodulation by neuropeptide Y?Neurosci Lett. 1985;54: 117-121.
12.
Smith-White MA, Hardy TA, Brock JA, Potter EK.Effects of a selective neuropeptide Y Y2 receptor antagonist, BIIE0246, on Y2 receptors at peripheral neuroeffector junctions. Br J Pharmacol. 2001;132: 861-868.
13.
Ilebekk A, Björkman J-A, Nordlander M.Influence of endogenous neuropeptide Y (NPY) on the sympathetic-parasympathetic interaction in the canine heart. J Cardiovasc Pharmacol. 2005;46: 474-480.
14.
Doods H, Gaia W, Wieland HA, et al.BIIE0246: a selective and high affinity neuropeptide Y Y2 receptor antagonist. Eur J Pharmacol. 1999;384: R3-R5.
15.
Grund F, Sommerschild HT, Kirkebøen KA, Ilebekk A.Proarrhythmic effects of ischemic preconditioning in anesthetized pigs. Basic Res Cardiol. 1997;92: 417-425.
16.
Ovize M, Aupetit JF, Rioufol G.Preconditioning reduces infarct size but accelerates the time to ventricular fibrillation in ischemic pig heart. Am J Physiol. 1995; 269: H72-H79.
17.
Rioufol G, Ovize M, Loufoua J.Ventricular fibrillation in preconditioned pig hearts: role of K+ATP channels. Am J Physiol. 1997;273: H2804-H2810.
18.
Ilebekk A, Aspelin T, Eriksen M, Larsen A, Lyberg T.Reduced release of vasoconstrictors from the porcine heart after repeated periods of ischemia. Scand Cardiovasc J. 2005;39: 60-66.
19.
Lameris TW, de Zeeuw S, Alberts G, et al.Time course and mechanism of myocardial catecholamine release during transient ischemia in vivo. Circulation. 2000;101: 2645-2650.
20.
Pernow J, Lundberg JM, Kaiser L.Plasma neuropeptide Y-like immunoreactivity and catecholamines during various degrees of sympathetic activation in man. Clin Physiol. 1986;6: 561-578.
21.
Pernow J, Lundberg JM, Kaiser L.Vasoconstrictor effects in vivo and plasma disappearance of neuropeptide Y in man. Life Sci. 1987;40: 47-54.
22.
Myers RW, Pearlman AS, Hyman RM, et al.Beneficial effects of vagal stimulation and bradycardia during experimental acute myocardial ischemia. Circulation. 1974;49: 943-947.
23.
Schwartz PJ, Billman GE, Stone HL.Autonomic mechanisms in ventricular fibrillation induced by myocardial ischemia during exercise in dogs with healed myocardial infarction. An experimental preparation for sudden cardiac death. Circulation. 1984;69: 790-800.
24.
Schwartz PJ, Vanoli E, Stramba-Badiale M, De Ferrari GM, Billman GE, Foreman RD.Autonomic mechanisms and sudden death. New insights from analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction. Circulation. 1988; 78: 969-979.
25.
De Ferrari GM, Vanoli E, Stramba-Badiale M, Hull SS Jr, Foreman RD, Schwartz PJ.Vagal reflexes and survival during acute myocardial ischemia in conscious dogs with healed myocardial infarction. Am J Physiol. 1991;261: H63-H69.
26.
Vanoli E, De Ferrari GM, Stramba-Badiale M.Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction. Circ Res. 1991;68: 1471-1481.
27.
Anonymous. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J. 1996;17: 354-381.
28.
La Rovere MT, Bigger JT Jr, Marcus FI, Mortara A, Schwartz PJ.Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic tone and reflexes after myocardial infarction) Investigators. Lancet. 1998;351: 478-484.
29.
Malmström RE, Lundberg JON, Weitzberg E.Effects of the neuropeptide Y Y2 receptor antagonist BIIE0246 on sympathetic transmitter release in the pig in vivo. Naunyn-Schmiedeberg's Arch Pharmacol. 2002;365: 106-111.
30.
Dumont Y, Cadieux A, Doods H, et al.BIIE0246, a potent and highly selective non-peptide neuropeptide Y Y(2) receptor antagonist. Br J Pharmacol. 2000;129: 1075-1088.
